Boris D. Heifets

4.1k total citations · 1 hit paper
55 papers, 2.6k citations indexed

About

Boris D. Heifets is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Clinical Psychology. According to data from OpenAlex, Boris D. Heifets has authored 55 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cellular and Molecular Neuroscience, 21 papers in Pharmacology and 15 papers in Clinical Psychology. Recurrent topics in Boris D. Heifets's work include Neurotransmitter Receptor Influence on Behavior (21 papers), Psychedelics and Drug Studies (14 papers) and Treatment of Major Depression (13 papers). Boris D. Heifets is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (21 papers), Psychedelics and Drug Studies (14 papers) and Treatment of Major Depression (13 papers). Boris D. Heifets collaborates with scholars based in United States, Switzerland and Canada. Boris D. Heifets's co-authors include Pablo E. Castillo, Robert C. Malenka, Vivien Chevaleyre, Alan F. Schatzberg, Pascal S. Kaeser, Thomas C. Südhof, Jessica J. Walsh, Christine Blasey, Keith Sudheimer and Jessica Hawkins and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Boris D. Heifets

51 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials

2022 133 citations Boris D. Heifets et al. profile →

Peers

Boris D. Heifets

CMN

PHARM

CN

CP

MB

M. Victoria Puig Spain

Patricia Robledo Spain

David Nutt United Kingdom

Mostafa El Mansari Canada

Pau Celada Spain

Sharon Rosenzweig‐Lipson United States

Albert Adell Spain

Nasser Haddjeri France

Rudy Schreiber Netherlands

Matthew S. Milak United States

M. Victoria Puig Spain

Boris D. Heifets

2.1k ×1.5

CMN

387 ×0.4

PHARM

1.2k ×1.6

CN

361 ×0.6

CP

870 ×1.9

MB

Citations per year, relative to Boris D. Heifets Boris D. Heifets (= 1×) peers M. Victoria Puig

Countries citing papers authored by Boris D. Heifets

Since Specialization

Citations

This map shows the geographic impact of Boris D. Heifets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris D. Heifets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris D. Heifets more than expected).

Fields of papers citing papers by Boris D. Heifets

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris D. Heifets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris D. Heifets. The network helps show where Boris D. Heifets may publish in the future.

Co-authorship network of co-authors of Boris D. Heifets

This figure shows the co-authorship network connecting the top 25 collaborators of Boris D. Heifets. A scholar is included among the top collaborators of Boris D. Heifets based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris D. Heifets. Boris D. Heifets is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Heifets, Boris D., et al.. (2025). History, pharmacology and therapeutic mechanisms of 3,4‐methylenedioxymethamphetamine (MDMA). British Journal of Pharmacology.

2.

Pomrenze, Matthew B., et al.. (2025). 5-HT2C receptors in the nucleus accumbens constrain the rewarding effects of MDMA. Molecular Psychiatry. 30(11). 5405–5416. 2 indexed citations

3.

Gregory, Nicholas, et al.. (2025). Psilocybin Has No Analgesic Properties in Multiple Mouse Models of Acute and Chronic Pain. Journal of Pain. 29. 104862–104862. 1 indexed citations

4.

Santoro, Matteo, Rachel Lam, Nay L. Saw, et al.. (2025). Mapping of catecholaminergic denervation, neurodegeneration, and inflammation in 6-OHDA-treated Parkinson’s disease mice. npj Parkinson s Disease. 11(1). 28–28.

5.

Smith, A., et al.. (2024). Prevalence and characteristics of preoperative patients with depression. British Journal of Anaesthesia. 133(1). 77–85. 2 indexed citations

6.

Evans, Andrew K., Rachel Lam, Christine Xu, et al.. (2024). Impact of noradrenergic inhibition on neuroinflammation and pathophysiology in mouse models of Alzheimer’s disease. Journal of Neuroinflammation. 21(1). 322–322. 8 indexed citations

7.

Rein, Benjamin, Jie Zhang, Robyn St. Laurent, et al.. (2024). MDMA enhances empathy-like behaviors in mice via 5-HT release in the nucleus accumbens. Science Advances. 10(17). eadl6554–eadl6554. 14 indexed citations

8.

Szigeti, Balázs & Boris D. Heifets. (2024). Expectancy Effects in Psychedelic Trials. Biological Psychiatry Cognitive Neuroscience and Neuroimaging. 9(5). 512–521. 33 indexed citations

9.

Bandeira, Igor D., Jason Tucciarone, Ian H. Kratter, et al.. (2024). 273. Comparing the Antisuicidal and Antidepressant Effects of Intravenous Ketamine in Major Depressive Episodes With Suicidal Ideation. Biological Psychiatry. 95(10). S211–S211.

10.

Lii, Theresa R., Ashleigh E. Smith, Robin L. Okada, et al.. (2023). Randomized trial of ketamine masked by surgical anesthesia in patients with depression. Nature Mental Health. 1(11). 876–886. 49 indexed citations

11.

Barbosa, Daniel A. N., Xue Zhang, Matthew B. Pomrenze, et al.. (2023). UNRAVELing the synergistic effects of psilocybin and environment on brain-wide immediate early gene expression in mice. Neuropsychopharmacology. 48(12). 1798–1807. 25 indexed citations

12.

Hack, Laura M., Xue Zhang, Boris D. Heifets, et al.. (2023). Ketamine’s acute effects on negative brain states are mediated through distinct altered states of consciousness in humans. Nature Communications. 14(1). 6631–6631. 11 indexed citations

13.

Barbosa, Daniel A. N., Allan Wang, Yuhao Huang, et al.. (2023). An orexigenic subnetwork within the human hippocampus. Nature. 621(7978). 381–388. 13 indexed citations

14.

McInnes, L. Alison, et al.. (2022). A retrospective analysis of ketamine intravenous therapy for depression in real-world care settings. Journal of Affective Disorders. 301. 486–495. 34 indexed citations

15.

Christoffel, Daniel J., Jessica J. Walsh, Boris D. Heifets, et al.. (2021). Input-specific modulation of murine nucleus accumbens differentially regulates hedonic feeding. Nature Communications. 12(1). 2135–2135. 41 indexed citations

16.

Wu, Yun, Yao Lu, Daryl L. Davies, et al.. (2019). A newly developed anesthetic based on a unique chemical core. Proceedings of the National Academy of Sciences. 116(31). 15706–15715. 14 indexed citations

17.

Heifets, Boris D., Paul Hoerbelt, Daniel F. Cardozo Pinto, et al.. (2019). Distinct neural mechanisms for the prosocial and rewarding properties of MDMA. Science Translational Medicine. 11(522). 72 indexed citations

18.

Hoerbelt, Paul & Boris D. Heifets. (2018). Native System and Cultured Cell Electrophysiology for Investigating Anesthetic Mechanisms. Methods in enzymology on CD-ROM/Methods in enzymology. 602. 301–338. 4 indexed citations

19.

Heifets, Boris D. & Robert C. Malenka. (2016). MDMA as a Probe and Treatment for Social Behaviors. Cell. 166(2). 269–272. 34 indexed citations

20.

Chevaleyre, Vivien, Boris D. Heifets, Pascal S. Kaeser, Thomas C. Südhof, & Pablo E. Castillo. (2007). Endocannabinoid-Mediated Long-Term Plasticity Requires cAMP/PKA Signaling and RIM1α. Neuron. 55(1). 169–169. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact